Human Transforming Growth Factor beta1 (TGF-β1) ELISA Kit

SKU: BE010025
Bon Opus Cat. #BE010025
  • Background

    Transforming growth factor beta (TGF-β) is a stable, multifunctional polypeptide growth factor. While specific receptors for this protein have been found on almost all mammalian cells examined, the effect of the molecule varies depending on the cell type and growth conditions. Generally, TGF-β is stimulatory for cells of mesenchymal origin and inhibitory of cells of epithelial or neuroectodermal origin. The originally described form of TGF-β, now designated TGF-β1, is only one member of a family of regulatory proteins consisting of a number of factors distantly related to TGF-β1 (30-40% sequence identity), including the activins, inhibins, and bone morphogenetic proteins (BMPs), and a number of more closely related proteins (70-80% sequence identity) designated TGF-β1, TGF-β2, TGF-β3, TGF-β4, and TGF-β5. 1-4 Most of the currently published reports on the activities of TGF-β have dealt only with TGF-β1. In general, TGF-β1, TGF-β2 and TGF-β3 appear to be functionally equivalent in biological activity in vitro, although there seem to be differences in potency on different cell types.5-8TGF-β1 has been found in the highest concentration in human platelets and mammalian bone, but it is produced in smaller amounts by many cells.1,2,9 TGF-β has a wide range of biological activities. With only a few exceptions, all cells have surface receptors for, and respond to TGF-β.1-4 TGF-β is an important modulator of the growth, differentiation, and activities of a number of the different types of cells involved in both cellular and humoral immune responses. TGF-β is a potent suppressor of the proliferation of T and B lymphocytes, thymocytes, and some immature hematopoietic cell populations.1-4,10 TGF-β1 enhances the deposition of extracellular matrix through promotion of synthesis and inhibition of degradation. TGF-β1 is immunosuppressive through a variety of mechanisms.11 The specific action of TGF-β1 on a particular cell depends on the exact circumstances of that cell's environment. The most commonly used bioassays for TGF-β1 are based on its anti-proliferative effects of various cell lines, e.g., mink lung epithelial cells (CCL64) 12 or HT-2 murine helper T cells. 13These assays require two days to complete and lack the specificity of distinguish between the various isoforms of TGF-β1. Human TGF-β1 ELISA Kit is a 3 hours solid phase ELISA designed to measure TGF-β1 in cell culture supernatant, serum and plasma. Results obtained using natural TGF-β1 showed linear curves that were parallel to the standard curves obtained using the CHO-derived kit standards. Since TGF-β1 is not glycosylated, it is virtually certain that the Human TGF-β1 ELISA Kit will provide accurate quantitation for both recombinant and natural TGF-β. This TGF-β1 ELISA is a 3.5 hour solid phase immunoassay readily applicable to measure TGF-β1 levels in serum, plasma, cell culture supernatant, and other biological fluids in the range of 0 to 2000 pg/mL. It showed no cross reactivity with various other cytokines. This TGF-β1 ELISA is expected to be effectively used for further investigations into the relationship between TGF-β1 and various diseases.
  • ALTnames

    Transforming growth factor beta-1, TGF-beta-1, Latency-associated peptide, LAP, TGFB1, TGFB

(800) 943-6396

150 Essex St, Millburn, NJ 07041, USA

©2020 by Bon Opus Biosciences, LLC.